FGF2 and ovarian cancer: Overexpression of E-cadherin decreased basal invasiveness and abolished the ability of FGF2 to induce ovarian cancer cell invasion (Fig 6B), implicating that E-cadherin plays an essential role in FGF-stimulated ovarian cancer cell invasion.